Search

Displaying results 7501 - 7510 of 10000 in total
  1. Drug

    Bofutrelvir

    go.drugbank.com/drugs/DB21501
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Bofutrelvir is a antiviral 3CL protease inhibitor. Bofutrelvir has a monoisotopic molecular weight of 452.24 Da.

  2. Drug

    Ulecaciclib

    go.drugbank.com/drugs/DB21595
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Ulecaciclib is a cyclin dependant kinase inhibitor. Ulecaciclib has a monoisotopic molecular weight of 496.25 Da.

  3. Drug

    Eciruciclib

    go.drugbank.com/drugs/DB21597
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Eciruciclib is a cyclin dependant kinase inhibitor. Eciruciclib has a monoisotopic molecular weight of 488.28 Da.

  4. Drug

    Zevotrelvir

    go.drugbank.com/drugs/DB21638
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor. Zevotrelvir has a monoisotopic molecular weight of 537.2 Da.

  5. Drug

    Orenasitecan

    go.drugbank.com/drugs/DB21718
    Experimental

    The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor. Orenasitecan has a monoisotopic molecular weight of 1470.58 Da.

  6. Drug

    Mocaciclib

    go.drugbank.com/drugs/DB21730
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor. Mocaciclib has a monoisotopic molecular weight of 609.3 Da.

  7. Drug

    MD-0727

    go.drugbank.com/drugs/DB05948
    Investigational

    MD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.

  8. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).

  9. Drug

    NV-52

    go.drugbank.com/drugs/DB05673
    Experimental

    NV-52 is an investigational synthetic flavonoid thromboxane synthase (TXS) inhibitor developed for the maintenance of remission in inflammatory bowel disease.

  10. Drug

    DTX-101

    go.drugbank.com/drugs/DB17699
    Investigational

    It was previously investigated for the treatment of hemophilia B; however, the clinical development of DTX-101 was discontinued.[L46103] … DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector encoding the human Factor Ix gene.